Company Filing History:
1 out of 2 
1 out of 1 
1 out of 7 Years Active: 1990
Title: Jacek Grodner: Innovator in Antitumor Pharmaceutical Processes
Introduction
Jacek Grodner is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that yield compounds with antitumor activity. His innovative work has led to the granting of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Jacek Grodner holds a patent for a process for the production of 1,3,2-oxazaphosphorinanes. This process involves the production of derivatives of 1,3,2-oxazaphosphorinane of general formula 1, wherein R1 and R2 represent a hydrogen atom or a 2-halogenoalkyl group, with the stipulation that R1 and R2 cannot both be hydrogen atoms simultaneously. The invention is based on the reduction of the respective 3-halogenoacyl derivatives of 1,3,2-oxazaphosphorinane, utilizing sodium borohydride in the presence of boron trifluoride etherate. The derivatives produced through this method demonstrate promising antitumor activity, highlighting the potential impact of Grodner's work in cancer treatment.
Career Highlights
Throughout his career, Jacek Grodner has worked with esteemed organizations such as the Institute of Pharmaceutical Industry and the Center for Molecular and Macromolecular Studies. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to significant advancements in pharmaceutical research.
Collaborations
Jacek Grodner has collaborated with notable colleagues, including Wojciech J. Stec and Czeslaw Radzikowski. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality of research in which he is involved.
Conclusion
Jacek Grodner's contributions to the field of pharmaceuticals, particularly through his patented processes, underscore his role as an innovator in the industry. His work not only advances scientific knowledge but also holds the potential to improve treatment options for patients facing cancer.